Pancreatic Cancer Research

ResearcherHFR Freiburg KantonsspitalActive in the last 2 years

Bernhard Egger

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2099-3367; OpenAlex author ID A5075012148. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 4

  1. 3D modeling to predict vascular involvement in resectable pancreatic adenocarcinoma. Last author DOI 10.1016/j.heliyon.2024.e41473↗
  2. Massive Haematochezia due to Splenic Artery Bleeding into the Colon: Unusual Manifestation of Advanced Pancreatic Cancer. Last author DOI 10.1155/2023/7443508↗
  3. Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature. Last author DOI 10.1371/journal.pone.0252397↗
  4. Pancreatic Cancer: Feasibility and Outcome After Radiochemotherapy with High Dose External Radiotherapy for Non-resected and R1 Resected Patients. Co-author DOI 10.7759/cureus.2713↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Raffaella Sguinzi · 2 shared papers, 2023–2025 · strength 0.44
  2. Christian Toso · 1 shared paper, 2025 · strength 0.25
  3. Claudia Mellenthin · 1 shared paper, 2021 · strength 0.16
  4. Sarah Peisl · 1 shared paper, 2021 · strength 0.16
  5. Léo Bühler · 1 shared paper, 2021 · strength 0.16
  6. Abdelkarim Said Allal · 1 shared paper, 2018 · strength 0.09
  7. David Cédric Lauffer · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.